PELOSI, NANCY BUYNVDA$500K–$1M—·TUBERVILLE, TOMMY BUYMSFT$50K–$100K—·CRENSHAW, DAN SELLXOM$15K–$50K—·PELOSI, NANCY BUYNVDA$500K–$1M—·TUBERVILLE, TOMMY BUYMSFT$50K–$100K—·CRENSHAW, DAN SELLXOM$15K–$50K—·
← Leaderboard
CI
Ticker

CI

The Cigna Group
HOSPITAL & MEDICAL SERVICE PLANS
Congressional Trades
63
by 10 members
Buys
27
43%
Sells
36
57%
Total Volume
$627K
midpoint
Unique Traders
10
members

Party Breakdown

Democrats53 · 84%
Republicans10 · 16%

Party Trading Divergence

Democrat vs. Republican buy / sell pressure by monthMODERATE

Bar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.

Democrat ←
Month
→ Republican
1▲
Apr '23
—
1▲
May '23
—
—
Dec '23
0▲1▼
0▲2▼
May '24
—
1▲
Jul '24
—
1▲1▼
Aug '24
—
2▲
Oct '24
1▲
3▲1▼
Jan '25⚡
0▲1▼
1▲
Feb '25
1▲1▼
3▲2▼
Mar '25
—
—
Apr '25
0▲2▼
4▲
May '25⚡
0▲2▼
0▲1▼
Jul '25
—
0▲5▼
Aug '25
—
1▲6▼
Sep '25
—
1▲
Oct '25
—
0▲5▼
Nov '25
—
2▲2▼
Dec '25
—
1▲
Jan '26
—
2▲
Feb '26
—
0▲4▼
Mar '26
—
Democrats24▲29▼Neutral
vs
Republicans2▲7▼Net sellers
Net buyingNet selling⚡ Party split

💼 Lobbying Filings

all →
  • 2026-04-21$50K
    CIGNA
    Pharmacy issues related to TRICARE. Issues surrounding pharmacy benefit managers, and coverage of biosimilars.
  • 2026-04-20$3.5M
    THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
    Issues related to prior authorization; ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model Issues relating to implementation of the No Surprises Act H.R. 3838/S2296 Pharmacy issues related to the National Defense Authorization Act, FY2026 HR. 6400 / S. 4106 - Rx Access, Choice, Cost Equity, and Supply Stability (Rx ACCESS) Act S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act; P.L. 119-75 Consolidated Appropriations Act, 2026 (H.R.7148) Issues related to the specialty drug market. H.R. 5582/S. 2355, Patients Deserve Price Tags Act Issues related to competition in the health care marketplace.
  • 2026-04-20$1.7M
    THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)
    Issues related to prior authorization. S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) including in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA); Issues relating to implementation of the No Surprises Act. H.R. 3838/S. 2296 Pharmacy issues related to the National Defense Authorization Act, FY2026. "S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act." Issues related to the specialty drug market. Issues related to transparency. Issues related to competition in the health care marketplace.
  • 2026-04-20$90K
    CIGNA CORPORATION AND SUBSIDIARIES
    Issues related to pharmacy and prescription drug pricing; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169); Issues relating to implementation of the No Surprises Act (PL 116-260). Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60). Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
  • 2026-04-20$60K
    THE CIGNA GROUP AND SUBSIDIARIES
    Issues related to commercial insurance and pharmacy benefits. H.R.4710: No Surprises Act. H.R.7895: PBM Kickback Prohibition Act.
  • 2026-04-19$20K
    THE CIGNA GROUP AND SUBSIDIARIES (FKA CIGNA CORPORATION AND SUBSIDIARIES)
    Pharmacy issues related to TRICARE; FY2027 Department of Defense Appropriations, FY2027 National Defense Authorization Act Issues related to P.L. 116-260, the No Surprises Act
  • 2026-04-17$90K
    CIGNA CORPORATION
    Educate lawmakers on issues related to pharmacy benefit managers and drug pricing; proposals impacting employer-sponsored insurance; and proposals related to telehealth. Monitor pharmacy issues related to TRICARE.
  • 2026-04-17$90K
    CIGNA CORPORATION
    Provide advice and counsel on healthcare coverage, surprise billing, drug pricing and Affordable Care Act issues Drug pricing and issues facing the pharmacy benefit manager industry generally
  • 2026-04-17$50K
    CIGNA CORPORATE SERVICES LLC AND ITS AFFILIATES
    Issues related to health care policy including coverage and cost of care.
  • 2026-04-16$0
    THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

Congressional Momentum

buy vs. sell pressureDISTRIBUTING

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days
No trades
Last 90 Days
▼33
2 buys6 total4 sells
$16K buys · $32K sells
All-Time
▼38
27 buys63 total36 sells
$241K buys · $386K sells
Cumulative Net Position (buy vol − sell vol)
-$146K
2021-1263 trades plotted2026-03

Trade Activity Timeline

Congressional buys & sells by month · last 22 months w/ activity

21/12
23/04
23/05
23/12
24/05
24/07
24/08
24/10
25/01
25/02
25/03
25/04
25/05
25/07
25/08
25/09
25/10
25/11
25/12
26/01
26/02
26/03
BuysSellsOtherHigh-volume month

Who Moved First

each row = one member · sorted by earliest disclosed trade
9 buyers ·9 sellers
2023202420252026RJerry Moran2×2021-12-21 · buy · $8K2023-12-14 · sell · $8KDLois Frankel2×2023-04-05 · buy · $8K2023-05-31 · buy · $8KDRo Khanna19×2024-05-28 · sell · $33K2024-05-29 · sell · $8K2024-07-01 · buy · $8K2024-08-02 · sell · $33K2024-08-02 · buy · $8K2024-10-14 · buy · $8K2025-01-17 · buy · $8K2025-01-22 · buy · $8K2025-02-25 · buy · $8K2025-03-12 · buy · $8K2025-07-25 · sell · $8K2025-08-04 · sell · $8K2025-09-05 · buy · $8K2025-09-29 · sell · $8K2025-10-07 · buy · $8K2025-11-10 · sell · $8K2026-01-13 · buy · $8K2026-02-17 · buy · $8K2026-02-24 · buy · $8KRJulia Letlow3×2024-10-23 · buy · $8K2025-04-22 · sell · $8K2025-04-22 · sell · $8KDValerie Hoyle3×2024-10-29 · buy · $8K2025-09-23 · sell · $8K2025-09-23 · sell · $8KRRobert Bresnahan2×2025-01-13 · sell · $8K2025-02-25 · sell · $8KDJulie Johnson14×2025-01-15 · buy · $8K2025-03-03 · sell · $8K2025-03-03 · sell · $8K2025-03-19 · buy · $8K2025-03-19 · buy · $8K2025-08-14 · sell · $8K2025-08-14 · sell · $8K2025-09-25 · sell · $8K2025-09-25 · sell · $8K2025-09-25 · sell · $8K2025-11-13 · sell · $8K2025-11-13 · sell · $8K2025-12-18 · sell · $8K2025-12-18 · sell · $8KDGilbert Cisneros9×2025-01-24 · sell · $8K2025-08-05 · sell · $8K2025-08-05 · sell · $8K2025-11-12 · sell · $8K2025-11-12 · sell · $8K2025-12-19 · buy · $8K2025-12-19 · buy · $8K2026-03-13 · sell · $8K2026-03-13 · sell · $8KRJefferson Shreve3×2025-02-24 · buy · $33K2025-05-12 · sell · $33K2025-05-12 · sell · $33KDJared Moskowitz6×2025-05-15 · buy · $8K2025-05-15 · buy · $8K2025-05-15 · buy · $8K2025-05-15 · buy · $8K2026-03-23 · sell · $8K2026-03-23 · sell · $8K
BuySellOtherDot size ∝ trade size · top 10 most-active traders shown

All Disclosed Trades

DateMemberActionAmountFiling Delay
2026-03-23DJared MoskowitzSELL$1K – $15K39d
2026-03-23DJared MoskowitzSELL$1K – $15K38d
2026-03-13DGilbert CisnerosSELL$1K – $15K26d
2026-03-13DGilbert CisnerosSELL$1K – $15K25d
2026-02-24DRo KhannaBUY$1K – $15K13d
2026-02-17DRo KhannaBUY$1K – $15K20d
2026-01-13DRo KhannaBUY$1K – $15K24d
2025-12-18DJulie JohnsonSELL$1K – $15K29d
2025-12-18DJulie JohnsonSELL$1K – $15K28d
2025-04-22RJulia LetlowSELL$1K – $15K267d
2025-12-19DGilbert CisnerosBUY$1K – $15K25d
2025-04-22RJulia LetlowSELL$1K – $15K266d
2024-10-23RJulia LetlowBUY$1K – $15K447d
2025-12-19DGilbert CisnerosBUY$1K – $15K24d
2025-11-12DGilbert CisnerosSELL$1K – $15K34d
2025-11-12DGilbert CisnerosSELL$1K – $15K33d
2025-11-13DJulie JohnsonSELL$1K – $15K29d
2025-11-13DJulie JohnsonSELL$1K – $15K28d
2025-11-10DRo KhannaSELL$1K – $15K28d
2025-10-07DRo KhannaBUY$1K – $15K30d
2025-09-23DValerie HoyleSELL$1K – $15K17d
2025-09-23DValerie HoyleSELL$1K – $15K17d
2025-09-25DJulie JohnsonSELL$1K – $15K13d
2025-09-25DJulie JohnsonSELL$1K – $15K12d
2025-09-25DJulie JohnsonSELL$1K – $15K12d
2025-09-29DRo KhannaSELL$1K – $15K4d
2025-09-05DRo KhannaBUY$1K – $15K28d
2025-08-05DGilbert CisnerosSELL$1K – $15K41d
2025-08-14DJulie JohnsonSELL$1K – $15K29d
2025-08-05DGilbert CisnerosSELL$1K – $15K38d
2024-10-29DValerie HoyleBUY$1K – $15K318d
2025-08-14DJulie JohnsonSELL$1K – $15K28d
2025-08-04DRo KhannaSELL$1K – $15K36d
2025-07-25DRo KhannaSELL$1K – $15K13d
2025-05-15DJared MoskowitzBUY$1K – $15K46d
2025-05-15DJared MoskowitzBUY$1K – $15K43d
2025-05-12RJefferson ShreveSELL$15K – $50K42d
2025-05-12RJefferson ShreveSELL$15K – $50K41d
2025-05-15DJared MoskowitzBUY$1K – $15K16d
2025-05-15DJared MoskowitzBUY$1K – $15K16d
2025-03-19DJulie JohnsonBUY$1K – $15K26d
2025-03-03DJulie JohnsonSELL$1K – $15K42d
2025-03-12DRo KhannaBUY$1K – $15K29d
2025-03-03DJulie JohnsonSELL$1K – $15K36d
2025-03-19DJulie JohnsonBUY$1K – $15K15d
2025-02-25RRobert BresnahanSELL$1K – $15K30d
2025-02-24RJefferson ShreveBUY$15K – $50K13d
2025-02-25DRo KhannaBUY$1K – $15K9d
2025-01-13RRobert BresnahanSELL$1K – $15K31d
2025-01-15DJulie JohnsonBUY$1K – $15K28d
2025-01-24DGilbert CisnerosSELL$1K – $15K18d
2025-01-22DRo KhannaBUY$1K – $15K15d
2025-01-17DRo KhannaBUY$1K – $15K20d
2024-10-14DRo KhannaBUY$1K – $15K25d
2024-08-02DRo KhannaSELL$15K – $50K35d
2024-08-02DRo KhannaBUY$1K – $15K35d
2024-07-01DRo KhannaBUY$1K – $15K37d
2024-05-29DRo KhannaSELL$1K – $15K7d
2024-05-28DRo KhannaSELL$15K – $50K8d
2023-12-14RJerry MoranSELL$1K – $15K34d
2021-12-21RJerry MoranBUY$1K – $15K615d
2023-05-31DLois FrankelBUY$1K – $15K22d
2023-04-05DLois FrankelBUY$1K – $15K23d